European Commission approves Inrebic for newly diagnosed and previously treated myelofibrosis Feb. 9, 2021
Reduction of NK-activating ligand NKG2DL contributes to immune scape in SCLC and neuroblastoma Feb. 9, 2021
Onxeo partners with Institut Curie to study AsiDNA with radiotherapy in pediatric high-grade glioma Feb. 9, 2021
RSS